Oxygen is used as a medical treatment in both chronic and acute cases, and can be used in hospital, pre-hospital or entirely out of hospital, dependent on the needs of the patient and their medical conditions. The hyperbaric oxygen therapy (HBOT) devices involves breathing oxygen in a pressurized chamber in which the atmospheric pressure is raised up to three times higher than normal. Under these conditions, the lungs can gather up to three times more oxygen than would be possible breathing oxygen at normal air pressure. An increase in blood oxygen may improve oxygen delivery for vital tissue function to help fight infection or minimize injury.
The global hyperbaric oxygen therapy devices market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global hyperbaric oxygen therapy devices market segmentation is based on product types (monoplace HBOT devices, multiplace HBOT devices, topical HBOT devices), and its applications (air or gas embolism, decompression sickness, infection treatment, wound healing, etc.).
The global hyperbaric oxygen therapy devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global hyperbaric oxygen therapy devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.